1. Home
  2. News
  3. Vectus Biosystems Limited
  4. A Significant Milestone for VB0004
More Vectus Biosystems Limited news
Vectus Biosystems LimitedASX: VBS

A Significant Milestone for VB0004

Feb 20, 2022 at 9:40 PM EST · Issued by Vectus Biosystems Limited

Filed with ASX · Feb 20, 2022 at 9:40 PM EST · 2 pages · English

On 6ix: 6ix.com/news/a-significant-milestone-for-vb0004

Vectus Biosystems Limited on 6ix

Earlier from Vectus Biosystems

  • Chairman & CEO Address to ShareholdersJan 24, 2022
  • Third S.A.D. Group Reviewed By Trial Safety Review CommitteeNov 28, 2021
  • Response to ASX Price and Volume QueryOct 19, 2021
  • Update on Phase I Human TrialSep 6, 2021
  • Successful Completion of First Group in Phase I Human TrialAug 23, 2021

Later from Vectus Biosystems

  • Half Yearly Report and Appendix 4DFeb 25, 2022
  • Completion of Final S.A.D. Study and First M.A.D. StudyMay 25, 2022
  • Quarterly Activities Report & Appendix 4CJul 28, 2022
  • Completion of Second M.A.D. Study for VB0004Aug 8, 2022
  • Completion of Phase Ia for VB0004Sep 14, 2022
All Vectus Biosystems news releases↗

Follow Vectus Biosystems into a list and get an email when it puts out news.

Follow Vectus Biosystems
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer